WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting

Private Equity

Open PDF
  • Trusted by Sophisticated Deal Makers

    Wilson Sonsini's financial sponsor clients range from some of the largest diversified private equity firms in the world to mid-market, industry-focused investment and buyout funds, as well as earlier-stage investment firms.

  • Breadth of Practice

    Our attorneys advise on a range of buyout and investment transactions, including public company going-private deals, senior and mezzanine transaction financings, restructurings and recapitalizations, divisional spin-offs and carve outs, PIPEs, private-company buyouts, and VC investments.

  • International Experience

    Wilson Sonsini has developed a strong and thriving private equity practice in Greater China and neighboring regions with an outstanding record of advising on private equity-sponsored deals and going-private transactions.

Wilson Sonsini provides counsel to leading private equity and growth equity funds, as well as other financial sponsors, in buyout and investment transactions, including: 

  • Public company "taking private" or "going private" deals
  • Senior and mezzanine transaction financings
  • Restructurings and recapitalizations
  • Divisional spin-offs and carve outs
  • Private investments in public equity (PIPEs)
  • Private company buyouts
  • Growth and later-stage financings
  • Venture capital investments
  • Various portfolio company transactions

Wilson Sonsini financial sponsor clients range from some of the world's largest diversified private equity firms to mid-market, industry-focused investment and buyout funds, as well as earlier-stage investment firms.

The firm's private equity clients are sophisticated deal makers who demand creativity, flexibility, differentiated insight, and disciplined and nimble execution from their legal counsel. Our interdisciplinary team of seasoned private equity attorneys in the U.S. and Greater China are experienced at working with financial sponsors in highly competitive markets and the team has consistently helped private equity clients complete successful transactions. The team also draws upon the firm's broad experience in capital markets and debt financing, mergers and acquisitions, intellectual property and licensing, corporate governance, tax, employee benefits and compensation, and antitrust and other regulatory matters.

Our objective is to meet the sophisticated needs of financial sponsors involved in buyout and investment transactions, including actionable risk evaluation, downside protection strategies, tax-efficient structuring, and market intelligence. The firm's market-leading experience representing enterprises, also enables Wilson Sonsini to add value to our clients' investments after each deal is completed.

In addition to Wilson Sonsini's accomplished private equity team in the U.S., the firm has developed a strong and thriving practice in Greater China and neighboring regions. The firm's China-based attorneys are recognized experts in U.S. and Hong Kong private equity, capital markets, mergers and acquisitions, and corporate governance. The team has an outstanding record of advising on private equity-sponsored deals and going-private transactions, including, for example, the first private-equity-sponsored going-private transaction of a Hong Kong-listed company and the first successful private equity investor-led board and management reshuffling of a U.S.-listed Chinese company. 

Wilson Sonsini's established reputation for representing innovative companies in the technology, life sciences, and renewable energy industries puts us in an ideal position to share our insights into market practices and the key value drivers for transactions. The same foundation of experience also enables us to assist clients in the otherwise difficult process of separating technology, intellectual property, personnel, and other assets and liabilities in carve-out transactions. And finally, our experience conducting comprehensive due-diligence analysis facilitates decisive actions aimed at achieving business objectives.

Overview

Wilson Sonsini provides counsel to leading private equity and growth equity funds, as well as other financial sponsors, in buyout and investment transactions, including: 

  • Public company "taking private" or "going private" deals
  • Senior and mezzanine transaction financings
  • Restructurings and recapitalizations
  • Divisional spin-offs and carve outs
  • Private investments in public equity (PIPEs)
  • Private company buyouts
  • Growth and later-stage financings
  • Venture capital investments
  • Various portfolio company transactions

Wilson Sonsini financial sponsor clients range from some of the world's largest diversified private equity firms to mid-market, industry-focused investment and buyout funds, as well as earlier-stage investment firms.

The firm's private equity clients are sophisticated deal makers who demand creativity, flexibility, differentiated insight, and disciplined and nimble execution from their legal counsel. Our interdisciplinary team of seasoned private equity attorneys in the U.S. and Greater China are experienced at working with financial sponsors in highly competitive markets and the team has consistently helped private equity clients complete successful transactions. The team also draws upon the firm's broad experience in capital markets and debt financing, mergers and acquisitions, intellectual property and licensing, corporate governance, tax, employee benefits and compensation, and antitrust and other regulatory matters.

Our objective is to meet the sophisticated needs of financial sponsors involved in buyout and investment transactions, including actionable risk evaluation, downside protection strategies, tax-efficient structuring, and market intelligence. The firm's market-leading experience representing enterprises, also enables Wilson Sonsini to add value to our clients' investments after each deal is completed.

In addition to Wilson Sonsini's accomplished private equity team in the U.S., the firm has developed a strong and thriving practice in Greater China and neighboring regions. The firm's China-based attorneys are recognized experts in U.S. and Hong Kong private equity, capital markets, mergers and acquisitions, and corporate governance. The team has an outstanding record of advising on private equity-sponsored deals and going-private transactions, including, for example, the first private-equity-sponsored going-private transaction of a Hong Kong-listed company and the first successful private equity investor-led board and management reshuffling of a U.S.-listed Chinese company. 

Wilson Sonsini's established reputation for representing innovative companies in the technology, life sciences, and renewable energy industries puts us in an ideal position to share our insights into market practices and the key value drivers for transactions. The same foundation of experience also enables us to assist clients in the otherwise difficult process of separating technology, intellectual property, personnel, and other assets and liabilities in carve-out transactions. And finally, our experience conducting comprehensive due-diligence analysis facilitates decisive actions aimed at achieving business objectives.

Client Highlights
Wilson Sonsini Advises Sense on Strategic Investment from Analog Devices
On January 27, 2026, Sense, a leader in grid edge intelligence, announced it has received a strategic investment from Analog Devices, Inc. (ADI), a global semiconductor leader that bridges the physical and digital worlds to enable breakthroughs at the Intelligent Edge. This new investment enables further development of grid edge intelligence and management solutions for grid operators. Together, the companies will work with smart meter developers and others in the energy industry to accelerate the adoption of high-performance data and computation capabilities to enable a smarter grid. Wilson Sonsini Goodrich & Rosati advised Sense on the transaction.
Client Highlights
Wilson Sonsini Advises onX on Strategic Investment from TCV
On November 3, 2025, onX, a pioneer in digital outdoor navigation and mapping software, announced a strategic investment from TCV, a leading growth equity firm known for supporting enduring consumer technology brands. The partnership brings additional operational expertise and long-term support as onX continues to scale its suite of adventure-specific navigation apps and redefine the outdoor experience. The company's existing investors, including Summit Partners, Madison Valley Partners, and onX founder Eric Siegfried, will remain active board members. Wilson Sonsini Goodrich & Rosati advised onX on the transaction.
Client Highlights
Wilson Sonsini Advises Entrata on $200 Million Investment from Blackstone
On May 15, 2025, Entrata, a leading operating system for multifamily communities, announced a $200 million minority investment from funds managed by Blackstone at a $4.3 billion valuation. This investment comes as Entrata is moving forward on its next chapter of growth, serving the rental housing industry through innovative technology that streamlines operations for property managers and elevates the living experience for millions of residents. Wilson Sonsini Goodrich & Rosati advised Entrata on the transaction.

Entrata’s suite of solutions offers a centralized platform for managing various aspects of a property, including accounting, purchasing, facilities, and leasing, among others. Over the past two decades Entrata has emerged as a leader in property management technology, building a comprehensive operating system in rental housing. 
Client Highlights
Wilson Sonsini Advises Warburg Pincus on Stake Increase in United Family Healthcare
On March 13, 2025, United Family Healthcare (UFH), a leading high-end private healthcare services company in China, announced that Warburg Pincus, a global private equity investment leader, would further increase its stake in UFH. Upon completion of the transaction, Warburg Pincus will become a significant shareholder of UFH and secure a seat on the board of directors, and Fosun Pharma will exit from UFH.
Client Highlights
Wilson Sonsini Advises Qatalyst Partners on R1 RCM Inc.'s $8.9 Billion Acquisition by TowerBrook Capital Partners and Clayton, Dubilier & Rice
On July 31, 2024, R1 RCM Inc. (R1) announced that they have entered into a definitive agreement pursuant to which investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice will acquire R1, a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Transaction negotiations were led by a Special Committee of the Board of Directors of R1 (the Special Committee), which, as previously announced on March 11, 2024, was formed to evaluate strategic alternatives, advised by independent legal and financial advisors, and following the recommendation of the Special Committee, R1’s Board of Directors approved the transaction. Wilson Sonsini Goodrich & Rosati advised Qatalyst Partners, which served as a financial advisor to the Special Committee on the transaction.
Client Highlights
Wilson Sonsini Advises Ascentage Pharma on HK$585.77 Million (US$75 Million) Equity Investment from Takeda International in Connection with the Exclusive Global License for HQP1351 (olverembatinib)
Ascentage Pharma Group International (Ascentage Pharma) and Takeda Pharmaceuticals International AG (Takeda International) entered into an exclusive option agreement on June 14, 2024, where Takeda International is granted with an exclusive option to enter into an exclusive license agreement for HQP1351 (olverembatinib), a core drug candidate of Ascentage Pharma. In connection with such exclusive global arrangement, Ascentage Pharma and Takeda International also entered into a securities purchase agreement, pursuant to which Takeda International made a HK$585.77 million (US$75 million) equity investment in Ascentage Pharma to subscribe 24,307,322 shares of Ascentage Pharma at a purchase price of HK$24.09850 per share. The closing of such equity investment took place on June 20, 2024.
View All
Insights
Client Highlights
Wilson Sonsini Advises Sense on Strategic Investment from Analog Devices
On January 27, 2026, Sense, a leader in grid edge intelligence, announced it has received a strategic investment from Analog Devices, Inc. (ADI), a global semiconductor leader that bridges the physical and digital worlds to enable breakthroughs at the Intelligent Edge. This new investment enables further development of grid edge intelligence and management solutions for grid operators. Together, the companies will work with smart meter developers and others in the energy industry to accelerate the adoption of high-performance data and computation capabilities to enable a smarter grid. Wilson Sonsini Goodrich & Rosati advised Sense on the transaction.
Client Highlights
Wilson Sonsini Advises onX on Strategic Investment from TCV
On November 3, 2025, onX, a pioneer in digital outdoor navigation and mapping software, announced a strategic investment from TCV, a leading growth equity firm known for supporting enduring consumer technology brands. The partnership brings additional operational expertise and long-term support as onX continues to scale its suite of adventure-specific navigation apps and redefine the outdoor experience. The company's existing investors, including Summit Partners, Madison Valley Partners, and onX founder Eric Siegfried, will remain active board members. Wilson Sonsini Goodrich & Rosati advised onX on the transaction.
Client Highlights
Wilson Sonsini Advises Entrata on $200 Million Investment from Blackstone
On May 15, 2025, Entrata, a leading operating system for multifamily communities, announced a $200 million minority investment from funds managed by Blackstone at a $4.3 billion valuation. This investment comes as Entrata is moving forward on its next chapter of growth, serving the rental housing industry through innovative technology that streamlines operations for property managers and elevates the living experience for millions of residents. Wilson Sonsini Goodrich & Rosati advised Entrata on the transaction.

Entrata’s suite of solutions offers a centralized platform for managing various aspects of a property, including accounting, purchasing, facilities, and leasing, among others. Over the past two decades Entrata has emerged as a leader in property management technology, building a comprehensive operating system in rental housing. 
Client Highlights
Wilson Sonsini Advises Warburg Pincus on Stake Increase in United Family Healthcare
On March 13, 2025, United Family Healthcare (UFH), a leading high-end private healthcare services company in China, announced that Warburg Pincus, a global private equity investment leader, would further increase its stake in UFH. Upon completion of the transaction, Warburg Pincus will become a significant shareholder of UFH and secure a seat on the board of directors, and Fosun Pharma will exit from UFH.
Client Highlights
Wilson Sonsini Advises Qatalyst Partners on R1 RCM Inc.'s $8.9 Billion Acquisition by TowerBrook Capital Partners and Clayton, Dubilier & Rice
On July 31, 2024, R1 RCM Inc. (R1) announced that they have entered into a definitive agreement pursuant to which investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice will acquire R1, a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Transaction negotiations were led by a Special Committee of the Board of Directors of R1 (the Special Committee), which, as previously announced on March 11, 2024, was formed to evaluate strategic alternatives, advised by independent legal and financial advisors, and following the recommendation of the Special Committee, R1’s Board of Directors approved the transaction. Wilson Sonsini Goodrich & Rosati advised Qatalyst Partners, which served as a financial advisor to the Special Committee on the transaction.
Client Highlights
Wilson Sonsini Advises Ascentage Pharma on HK$585.77 Million (US$75 Million) Equity Investment from Takeda International in Connection with the Exclusive Global License for HQP1351 (olverembatinib)
Ascentage Pharma Group International (Ascentage Pharma) and Takeda Pharmaceuticals International AG (Takeda International) entered into an exclusive option agreement on June 14, 2024, where Takeda International is granted with an exclusive option to enter into an exclusive license agreement for HQP1351 (olverembatinib), a core drug candidate of Ascentage Pharma. In connection with such exclusive global arrangement, Ascentage Pharma and Takeda International also entered into a securities purchase agreement, pursuant to which Takeda International made a HK$585.77 million (US$75 million) equity investment in Ascentage Pharma to subscribe 24,307,322 shares of Ascentage Pharma at a purchase price of HK$24.09850 per share. The closing of such equity investment took place on June 20, 2024.
View All
Affiliated Programs
American Diabetes Association: 30th Annual Leaders Forum HealthTech Showcase
Wilson Sonsini is proud to sponsor the American Diabetes Association Leaders Forum.
Affiliated Programs
East Coast NextGen VC Forum 2025
LaunchBio’s NextGen VC Forum is the premiere event for mid-level venture capital associates to expand their skills and expertise while growing their network. Attendees benefit from curated education sessions from industry leaders to supplement existing expertise. Networking is essential in sourcing deals and one of the primary roles for associates, we’ve built it into the program for participants to be able to walk away with new life science and biotech contacts. The half-day forum created with Wilson Sonsini includes a networking lunch, three one-hour sessions, and a happy hour.
Affiliated Programs
A Conversation About Private Company Compensation
Wilson Sonsini and J.Thelander Consulting invite you to an in-depth compensation discussion followed by a networking reception. Wilson Sonsini partners Martin Luff and Fleur Benns – joined by Jody Thelander (Founder & CEO, J.Thelander Consulting) and Heather Preston (Senior Advisor, TPG) – will share real-time global compensation data, trends, and analysis for privately held life science and tech companies. We will examine all aspects of compensation and planning, as well as legal strategies covering your current and future needs, including: 
WSGR Events
College for Clients Series: Employee Equity Fundamentals - Private Companies
To help our privately held clients' stock administrators, in-house counsel, controllers, human resources personnel, and any others involved in stock plan administration better understand and manage their employee equity programs, we are hosting a webinar that will provide practical tips and materials on sound stock plan administration practices and equity compensation issues. The program will provide an overview of the fundamentals of equity compensation and a more detailed discussion of the legal issues involved in stock administration and compliance. It will focus on private companies ranging from early-stage start-ups to those contemplating public offerings.
Affiliated Programs
Silicon Valley Leaders Forum & The State of Diabetes: Northern California
Wilson Sonsini is proud to sponsor the American Diabetes Association Leaders Forum. This year, the State of Diabetes will be headlined by a breakfast and networking session. The State of Diabetes event includes a comprehensive panel discussion led by distinguished experts offering insights into topics impacting diabetes in our community. These discussions will be a catalyst for the Leaders Forum.
Affiliated Programs
NextGen VC Forum - NYC 2024
LaunchBio’s NextGen VC Forum is the premiere event for mid-level venture capital associates to expand their skills and expertise while growing their network. Attendees benefit from curated education sessions from industry leaders to supplement existing expertise. Networking is essential in sourcing deals and one of the primary roles for associates, we’ve built it into the program for participants to be able to walk away with new life science and biotech contacts. The half-day forum created with Wilson Sonsini includes a networking lunch, three one-hour sessions, and a happy hour.
View All
Events
Affiliated Programs
American Diabetes Association: 30th Annual Leaders Forum HealthTech Showcase
Wilson Sonsini is proud to sponsor the American Diabetes Association Leaders Forum.
Affiliated Programs
East Coast NextGen VC Forum 2025
LaunchBio’s NextGen VC Forum is the premiere event for mid-level venture capital associates to expand their skills and expertise while growing their network. Attendees benefit from curated education sessions from industry leaders to supplement existing expertise. Networking is essential in sourcing deals and one of the primary roles for associates, we’ve built it into the program for participants to be able to walk away with new life science and biotech contacts. The half-day forum created with Wilson Sonsini includes a networking lunch, three one-hour sessions, and a happy hour.
Affiliated Programs
A Conversation About Private Company Compensation
Wilson Sonsini and J.Thelander Consulting invite you to an in-depth compensation discussion followed by a networking reception. Wilson Sonsini partners Martin Luff and Fleur Benns – joined by Jody Thelander (Founder & CEO, J.Thelander Consulting) and Heather Preston (Senior Advisor, TPG) – will share real-time global compensation data, trends, and analysis for privately held life science and tech companies. We will examine all aspects of compensation and planning, as well as legal strategies covering your current and future needs, including: 
WSGR Events
College for Clients Series: Employee Equity Fundamentals - Private Companies
To help our privately held clients' stock administrators, in-house counsel, controllers, human resources personnel, and any others involved in stock plan administration better understand and manage their employee equity programs, we are hosting a webinar that will provide practical tips and materials on sound stock plan administration practices and equity compensation issues. The program will provide an overview of the fundamentals of equity compensation and a more detailed discussion of the legal issues involved in stock administration and compliance. It will focus on private companies ranging from early-stage start-ups to those contemplating public offerings.
Affiliated Programs
Silicon Valley Leaders Forum & The State of Diabetes: Northern California
Wilson Sonsini is proud to sponsor the American Diabetes Association Leaders Forum. This year, the State of Diabetes will be headlined by a breakfast and networking session. The State of Diabetes event includes a comprehensive panel discussion led by distinguished experts offering insights into topics impacting diabetes in our community. These discussions will be a catalyst for the Leaders Forum.
Affiliated Programs
NextGen VC Forum - NYC 2024
LaunchBio’s NextGen VC Forum is the premiere event for mid-level venture capital associates to expand their skills and expertise while growing their network. Attendees benefit from curated education sessions from industry leaders to supplement existing expertise. Networking is essential in sourcing deals and one of the primary roles for associates, we’ve built it into the program for participants to be able to walk away with new life science and biotech contacts. The half-day forum created with Wilson Sonsini includes a networking lunch, three one-hour sessions, and a happy hour.
View All
Weiheng Chen
Partner
Hong Kong
Weiheng leads Wilson Sonsini's Greater China practice and he focuses on capital markets, M&A, and private equity transactions.
  • Corporate
View Profile
Yang Chu
Partner
Hong Kong
Yang Chu is a corporate partner in the Hong Kong office of Wilson Sonsini Goodrich & Rosati. He has extensive experience advising clients on a broad range of corporate matters, including Hong Kong IPOs and follow-on equity and debt offerings, public and private M&A transactions and privatizations, and pre-IPO and cross-over financings. Yang also counsels Hong Kong-listed companies on post-listing compliance, corporate governance, executive compensation, and related regulatory matters.

Yang’s practice is focused on clients in the healthcare, life sciences, technology, media, consumer, and retail sectors, including corporates and their respective founders, executives, and private equity and venture capital investors.

Prior to joining the firm, Yang was a capital markets partner in the Hong Kong office of another international firm.

Yang is fluent in both Mandarin and English, and is conversational in Cantonese. 
  • Corporate
View Profile
Todd Cleary
Partner
San Francisco
Todd represents companies, investors and other parties in private equity transactions.
  • Mergers & Acquisitions
View Profile
Jennifer Fang
Partner
Boston
Jennifer helps innovative start-ups grow into successful enterprises by providing counsel to the founders, management teams, and boards.
  • Corporate
View Profile
Charlotte J. Kim
Partner
Boston
Charlotte’s practice focuses on global corporate finance with particular expertise in the energy, healthcare, life sciences and biotech, software, retail, manufacturing, aviation, materials science, foodtech, agtech, and tech sectors.
  • Corporate
View Profile
Sachin Kohli
Partner
New York
Sachin Kohli is a partner in the New York office of Wilson Sonsini Goodrich & Rosati. He has extensive experience in all aspects of representing public and private companies and private equity funds in a wide range of M&A transactions, including mergers, asset acquisitions, and divestitures. Sachin also counsels private and public companies on general corporate matters such as reporting requirements, corporate governance issues, defensive measures, and other strategic considerations.  
  • Mergers & Acquisitions
View Profile
Remi P. Korenblit
Partner
Seattle
Remi Korenblit is a partner at Wilson Sonsini Goodrich & Rosati, where his practice focuses on mergers and acquisitions, corporate governance, financing transactions, and other corporate and securities law matters. His transaction experience includes mergers, business combinations, asset and stock purchases, divestitures, carve-outs and spin-off transactions, private equity and venture financing transactions, joint ventures, and other strategic transactions for both public and private companies. He also advises clients on corporate governance matters, shareholder activism, takeover defense, recapitalizations and restructurings, and other special situations. Remi has represented U.S. and international clients in a variety of sectors, including software and technology, telecommunication, media, banking and finance, industrial, manufacturing, pharmaceutical, energy, and retail industries.
  • Corporate
View Profile
Martin W. Korman
Partner
Palo Alto
Marty represents technology and life sciences clients in M&A and other transformative deals.
  • Corporate
View Profile
Kathy H. Ku
Partner
Century City
Katherine H. Ku is a corporate and securities partner in the Los Angeles office of Wilson Sonsini Goodrich & Rosati. She represents both public and private companies and private equity funds in a variety of corporate transactions, including mergers and acquisitions, equity and debt financings, and joint ventures. Kathy also advises clients on corporate governance and securities compliance matters. In addition, she has experience representing special committees of boards of directors in connection with buy-out matters.
  • Mergers & Acquisitions
View Profile
Brandon J. Middleton-Pratt
Partner
Austin
Brandon J. Middleton-Pratt is a partner in the Austin office of Wilson Sonsini Goodrich & Rosati, where he specializes in representing emerging companies, mergers & acquisitions, private equity and other complex transactions, and venture capital financings. Brandon also provides strategic business advice and counsel to entrepreneurs and start-ups on a broad range of issues, including company formation, capitalization structure, equity compensation arrangements for founders and employees, negotiations with investors and acquirers, and other issues relevant to start-ups and high-growth companies.
  • Corporate
View Profile
View All
People
Weiheng Chen
Partner
Hong Kong
Weiheng leads Wilson Sonsini's Greater China practice and he focuses on capital markets, M&A, and private equity transactions.
  • Corporate
View Profile
Yang Chu
Partner
Hong Kong
Yang Chu is a corporate partner in the Hong Kong office of Wilson Sonsini Goodrich & Rosati. He has extensive experience advising clients on a broad range of corporate matters, including Hong Kong IPOs and follow-on equity and debt offerings, public and private M&A transactions and privatizations, and pre-IPO and cross-over financings. Yang also counsels Hong Kong-listed companies on post-listing compliance, corporate governance, executive compensation, and related regulatory matters.

Yang’s practice is focused on clients in the healthcare, life sciences, technology, media, consumer, and retail sectors, including corporates and their respective founders, executives, and private equity and venture capital investors.

Prior to joining the firm, Yang was a capital markets partner in the Hong Kong office of another international firm.

Yang is fluent in both Mandarin and English, and is conversational in Cantonese. 
  • Corporate
View Profile
Todd Cleary
Partner
San Francisco
Todd represents companies, investors and other parties in private equity transactions.
  • Mergers & Acquisitions
View Profile
Jennifer Fang
Partner
Boston
Jennifer helps innovative start-ups grow into successful enterprises by providing counsel to the founders, management teams, and boards.
  • Corporate
View Profile
Charlotte J. Kim
Partner
Boston
Charlotte’s practice focuses on global corporate finance with particular expertise in the energy, healthcare, life sciences and biotech, software, retail, manufacturing, aviation, materials science, foodtech, agtech, and tech sectors.
  • Corporate
View Profile
Sachin Kohli
Partner
New York
Sachin Kohli is a partner in the New York office of Wilson Sonsini Goodrich & Rosati. He has extensive experience in all aspects of representing public and private companies and private equity funds in a wide range of M&A transactions, including mergers, asset acquisitions, and divestitures. Sachin also counsels private and public companies on general corporate matters such as reporting requirements, corporate governance issues, defensive measures, and other strategic considerations.  
  • Mergers & Acquisitions
View Profile
Remi P. Korenblit
Partner
Seattle
Remi Korenblit is a partner at Wilson Sonsini Goodrich & Rosati, where his practice focuses on mergers and acquisitions, corporate governance, financing transactions, and other corporate and securities law matters. His transaction experience includes mergers, business combinations, asset and stock purchases, divestitures, carve-outs and spin-off transactions, private equity and venture financing transactions, joint ventures, and other strategic transactions for both public and private companies. He also advises clients on corporate governance matters, shareholder activism, takeover defense, recapitalizations and restructurings, and other special situations. Remi has represented U.S. and international clients in a variety of sectors, including software and technology, telecommunication, media, banking and finance, industrial, manufacturing, pharmaceutical, energy, and retail industries.
  • Corporate
View Profile
Martin W. Korman
Partner
Palo Alto
Marty represents technology and life sciences clients in M&A and other transformative deals.
  • Corporate
View Profile
Kathy H. Ku
Partner
Century City
Katherine H. Ku is a corporate and securities partner in the Los Angeles office of Wilson Sonsini Goodrich & Rosati. She represents both public and private companies and private equity funds in a variety of corporate transactions, including mergers and acquisitions, equity and debt financings, and joint ventures. Kathy also advises clients on corporate governance and securities compliance matters. In addition, she has experience representing special committees of boards of directors in connection with buy-out matters.
  • Mergers & Acquisitions
View Profile
Brandon J. Middleton-Pratt
Partner
Austin
Brandon J. Middleton-Pratt is a partner in the Austin office of Wilson Sonsini Goodrich & Rosati, where he specializes in representing emerging companies, mergers & acquisitions, private equity and other complex transactions, and venture capital financings. Brandon also provides strategic business advice and counsel to entrepreneurs and start-ups on a broad range of issues, including company formation, capitalization structure, equity compensation arrangements for founders and employees, negotiations with investors and acquirers, and other issues relevant to start-ups and high-growth companies.
  • Corporate
View Profile
View All

Representative private equity fund clients include:

  • Francisco Partners
  • General Atlantic
  • Marlin Equity Partners
  • Oak Hill Capital Partners
  • Silver Lake Partners
  • The Gores Group
  • Vector Capital
  • Warburg Pincus

Representative venture fund clients include:

  • Andreessen Horowitz
  • Austin Ventures
  • Kleiner Perkins Caufield & Byers
  • Mayfield Fund
  • Mohr Davidow Ventures
  • New Enterprise Associates
  • Sequoia Capital
  • VantagePoint Venture Partners

Representative private equity clients Wilson Sonsini has represented in China include:

  • Boyu Capital
  • L Capital Asia
  • New Horizon Capital
  • Sequoia Capital China
  • Warburg Pincus
Representative Clients

Representative private equity fund clients include:

  • Francisco Partners
  • General Atlantic
  • Marlin Equity Partners
  • Oak Hill Capital Partners
  • Silver Lake Partners
  • The Gores Group
  • Vector Capital
  • Warburg Pincus

Representative venture fund clients include:

  • Andreessen Horowitz
  • Austin Ventures
  • Kleiner Perkins Caufield & Byers
  • Mayfield Fund
  • Mohr Davidow Ventures
  • New Enterprise Associates
  • Sequoia Capital
  • VantagePoint Venture Partners

Representative private equity clients Wilson Sonsini has represented in China include:

  • Boyu Capital
  • L Capital Asia
  • New Horizon Capital
  • Sequoia Capital China
  • Warburg Pincus
Related Practices
  • Corporate
  • Mergers & Acquisitions
  • Special Purpose Acquisition Companies (SPACs)
Recent Insights
Client Highlights
Wilson Sonsini Advises Sense on Strategic Investment from Analog Devices
On January 27, 2026, Sense, a leader in grid edge intelligence, announced it has received a strategic investment from Analog Devices, Inc. (ADI), a global semiconductor leader that bridges the physical and digital worlds to enable breakthroughs at the Intelligent Edge. This new investment enables further development of grid edge intelligence and management solutions for grid operators. Together, the companies will work with smart meter developers and others in the energy industry to accelerate the adoption of high-performance data and computation capabilities to enable a smarter grid. Wilson Sonsini Goodrich & Rosati advised Sense on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises onX on Strategic Investment from TCV
On November 3, 2025, onX, a pioneer in digital outdoor navigation and mapping software, announced a strategic investment from TCV, a leading growth equity firm known for supporting enduring consumer technology brands. The partnership brings additional operational expertise and long-term support as onX continues to scale its suite of adventure-specific navigation apps and redefine the outdoor experience. The company's existing investors, including Summit Partners, Madison Valley Partners, and onX founder Eric Siegfried, will remain active board members. Wilson Sonsini Goodrich & Rosati advised onX on the transaction.
Learn More
View All
Recent Events
Affiliated Programs
American Diabetes Association: 30th Annual Leaders Forum HealthTech Showcase
Wilson Sonsini is proud to sponsor the American Diabetes Association Leaders Forum.
Learn More
Affiliated Programs
East Coast NextGen VC Forum 2025
LaunchBio’s NextGen VC Forum is the premiere event for mid-level venture capital associates to expand their skills and expertise while growing their network. Attendees benefit from curated education sessions from industry leaders to supplement existing expertise. Networking is essential in sourcing deals and one of the primary roles for associates, we’ve built it into the program for participants to be able to walk away with new life science and biotech contacts. The half-day forum created with Wilson Sonsini includes a networking lunch, three one-hour sessions, and a happy hour.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.